Evidence map›Paper›PMID 31926483›Full record

ReviewPediatric research2020

Surfactant replacement therapy: from biological basis to current clinical practice.

Roland Hentschel, Kajsa Bohlin, Anton van Kaam, Hans Fuchs, Olivier Danhaive

Open access · bronzeAbstract readReview
In one paragraph

Review in Pediatric research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 3 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 3 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Validation of a novel Bayesian predictive algorithm for detection of carbon dioxide retention using retrospective neonatal ICU data.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  12. Review
  13. Article
  14. Targeting CELA1 to Improve Septation in the Mouse Hyperoxia Model of Impaired Alveolar Development.American journal of respiratory cell and molecular biology · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Moving on from clinical animal-derived surfactants to peptide-based synthetic pulmonary surfactant.American journal of physiology. Lung cellular and molecular physiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 5 countries.

Roland HentschelDivision of Neonatology and Intensive Care, Department of Pediatrics and Adolescent Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany. roland.hentschel@uniklinik-freiburg.de.ORCID http://orcid.org/0000-0003-0411-4067
Kajsa BohlinDepartment of Neonatology, Karolinska University Hospital⁄Karolinska Institutet, Stockholm, Sweden.
Anton van KaamDepartment of Neonatology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Hans FuchsDivision of Neonatology and Intensive Care, Department of Pediatrics and Adolescent Medicine, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Olivier DanhaiveDivision of Neonatology, St-Luc University Hospital, Catholic University of Louvain, Brussels, Belgium.
University of Freiburg · DECliniques Universitaires Saint-Luc · BEEmma Kinderziekenhuis · NLKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review summarizes the current knowledge on the physiological action of endogenous and exogenous pulmonary surfactant, the role of different types of animal-derived and synthetic surfactants for RDS therapy, different modes of administration, potential risks and strategies of ventilation, and highlights the most promising aims for future development. Scientists have clarified the physicochemical properties and functions of the different components of surfactant, and part of this successful research is derived from the characterization of genetic diseases affecting surfactant composition or function. Knowledge from functional tests of surfactant action, its immunochemistry, kinetics and homeostasis are important also for improving therapy with animal-derived surfactant preparations and for the development of modified surfactants. In the past decade newly designed artificial surfactants and additives have gained much attention and have proven different advantages, but their particular role still has to be defined. For clinical practice, alternative administration techniques as well as postsurfactant ventilation modes, taking into account alterations in lung mechanics after surfactant placement, may be important in optimizing the potential of this most important drug in neonatology.

Indexed as

Adrenal Cortex HormonesAnimalsCattleCollectinsGenetic Diseases, InbornHomeostasisHumansHydrophobic and Hydrophilic InteractionsImmunochemistryInfantInfant, Low Birth WeightInfant, NewbornInfant, PrematureKineticsLungNeonatologyAdrenal Cortex HormonesCollectinsPulmonary Surfactants

Identifiers

PMID31926483
PMCPMC7223236
OpenAlexW2999914372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.